VTVT vTv Therapeutics Inc.

1.37
0  0%
Previous Close 1.37
Open
Price To Book -1.22
Market Cap 70,841,168
Shares 51,708,882
Volume 2,415
Short Ratio
Av. Daily Volume 930,079

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 (Part 1) data released June 6, 2019. Part 2 data due 1Q 2020.
TTP399
Type 1 Diabetes
Phase 2 data released August 2016. Primary endpoint met.
TTP399 - AGATA
Type 2 Diabetes
Phase 2 primary endpoint met - December 14, 2016.
TTP273 - LOGRA
Type 2 Diabetes
Phase 3 data both Part A (April 9, 2018) and Part B (June 12, 2018) did not meet endpoints.
Azeliragon - STEADFAST
Mild Alzheimer’s disease
Phase 2/3 screening to commence June 2019 with Phase 2 top-line data due 4Q 2020.
Azeliragon
Mild Alzheimer’s disease with type 2 diabetes

Latest News

  1. vTv Therapeutics Announces Positive Topline Results from Part 1 of the Phase 2 Simplici-T1 Trial in Patients with Type 1 Diabetes
  2. Biotech entrepreneur seeks approval of 80-acre Triad R&D campus with 1,600 jobs
  3. Insiders Roundup: vTv Therapeutics, The Hershey
  4. VTv Therapeutics: 1Q Earnings Snapshot
  5. vTv Therapeutics Announces 2019 First Quarter Financial Results and Update
  6. Zacks.com featured highlights include: VALE, Second Sight, Carbonite, Arconic and vTv
  7. Get Over Bargain Hunting: Tap 5 Stocks With Rising P/E
  8. FDA Events Can Send Stocks Soaring: Here's One That No One Is Talking About
  9. vTv Therapeutics to Present at the 14th International Conference on Alzheimer’s & Parkinson’s Diseases
  10. Triad biopharmaceutical company seeks to raise $6 million
  11. vTv Therapeutics Announces $15 Million of Class A Common Stock Financings
  12. vTv Therapeutics Announces 2018 Fourth Quarter and Full Year Financial Results and Update
  13. Watch These 4 Healthcare Stocks Set the Pace on Friday (1/25/19)
  14. vTv Therapeutics Announces Publication of Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study
  15. 10 trading lessons for 2019 that we learned from the 2018 stock market selloff
  16. Watch These Top Trending Stocks On Jan. 2, 2019
  17. Biotech Rally Ahead of the Market
  18. 4 Healthcare Stocks That Are Raising Eyebrows
  19. Biotech Companies in the News
  20. 4 Healthcare Stocks Gaining Speed on Friday (12/28/18)